Release Date: 26/02/19 08:36 Summary: Appendix 4E & FY2018 Preliminary Financial Report Price Sensitive: Yes Download Document 945.03KB Download
Webinar: What investors should know about what it takes for ASX-listed companies to get medical developments to market